The Blansetts are certainly glad they are alive. "By the grace of God, we are still here. It wasn't no human being that drug ...

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to robust long-term clinical responses and was well tolerated; ...